Concepedia

Lee Honigberg

LH

34

Publications

6.7K

Citations

25

H-Index

1996

Active since

Affiliations

Roche (Switzerland)(Current)

University of California, San Francisco

Pharmacyclics (United States)

University of California, Los Angeles

University of Bonn

Lee Honigberg is an author at Roche (Switzerland) specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1996–2025

34

Publications

34

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Lee Honigberg, Ashley M. Smith, Mint Sirisawad et al. · Proceedings of the National Academy of Sciences · 2010 · 1.5K citations · Full text

, , +16

A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid Arthritis

Ann B. Begovich, Victoria Carlton, Lee Honigberg et al. · The American Journal of Human Genetics · 2004 · 1.5K citations · Full text

, , +13

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 669 citations

, , +14

Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

Reina N. Fuji, Michael Flagella, Miriam Baca et al. · Science Translational Medicine · 2015 · 363 citations

Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration

Frank G. Holz, Srinivas R. Sadda, Brandon Busbee et al. · JAMA Ophthalmology · 2018 · 340 citations · Full text

Rows per page

1–5 of 34